Impaired tissue barriers as potential therapeutic targets for Parkinson’s disease and amyotrophic lateral sclerosis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Metabolic brain disease

• Publication date

  2018-04-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11011-018-0239-xPMID 29681010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients

  2017cited by this paper
• Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children.

  2017cited by this paper
• Vagotomy and Parkinson disease

  2017cited by this paper
• Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.

  2017cited by this paper
• Starke Belege: Parkinson könnte im Verdauungstrakt beginnen

  2017cited by this paper
• Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

  2017cited by this paper
• FDA approves edaravone for amyotrophic lateral sclerosis.

  2017cited by this paper
• Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

  2017cited by this paper
• Pharmacists mourn passing of University of Utah's Arthur Lipman, 72.

  2017cited by this paper
• Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet

  2017cited by this paper
• Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction

  2017cited by this paper
• Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.

  2017cited by this paper
• Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair

  2017cited by this paper
• Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson’s disease

  2017cited by this paper
• Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration

  2016cited by this paper
• Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.

  2016cited by this paper
• β‐asarone and levodopa co‐administration increase striatal dopamine level in 6‐hydroxydopamine induced rats by modulating P‐glycoprotein and tight junction proteins at the blood‐brain barrier and promoting levodopa into the brain

  2016cited by this paper
• CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease

  2016cited by this paper
• Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration

  2016cited by this paper
• Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

  2016cited by this paper
• Restoration of intestinal function in an MPTP model of Parkinson’s Disease

  2016cited by this paper
• Probiotics and prebiotic fiber for constipation associated with Parkinson disease

  2016cited by this paper
• Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.

  2016cited by this paper
• Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice.

  2016cited by this paper
• The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke

  2016cited by this paper
• TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.

  2016cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2016cited by this paper
• Parkinson's disease

  2016cited by this paper
• Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS

  2016cited by this paper
• Barrier function in the peripheral and central nervous system—a review

  2016cited by this paper
• Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis

  2016cited by this paper
• Permeability of blood–brain barrier in macaque model of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson disease

  2016cited by this paper
• Provotella‐derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease

  2015cited by this paper
• Structural alterations of the intestinal epithelial barrier in Parkinson’s disease

  2015cited by this paper
• Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

  2015cited by this paper
• Adenosine receptor signaling: a key to opening the blood–brain door

  2015cited by this paper
• Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

  2015cited by this paper
• The Enteric Glia: Identity and Functions

  2015cited by this paper
• Roles and regulation of the mucus barrier in the gut

  2015cited by this paper
• Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood–brain barrier in mice

  2015cited by this paper
• Vagotomy and subsequent risk of Parkinson's disease

  2015cited by this paper
• Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.

  2015cited by this paper
• Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner

  2015cited by this paper
• Increased CSF biomarkers of angiogenesis in Parkinson disease

  2015cited by this paper
• Blood-brain barrier dysfunction, seizures and epilepsy.

  2015cited by this paper
• Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression.

  2015cited by this paper
• Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies

  2015cited by this paper
• Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model

  2015cited by this paper
• P-Glycoprotein Transport of Neurotoxic Pesticides

  2015cited by this paper
• Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease.

  2015cited by this paper
• Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease

  2015cited by this paper
• Alterations of the blood‐spinal cord barrier in sporadic amyotrophic lateral sclerosis

  2015cited by this paper
• Expression of the ALS-Causing Variant hSOD1G93A Leads to an Impaired Integrity and Altered Regulation of Claudin-5 Expression in an in Vitro Blood–Spinal Cord Barrier Model

  2015cited by this paper
• Enhanced Delivery and Bioactivity of the Neurturin Neurotrophic Factor through Focused Ultrasound—Mediated Blood—Brain Barrier Opening in vivo

  2015cited by this paper
• Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit

  2015cited by this paper
• Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

  2015cited by this paper
• Colonic bacterial composition in Parkinson's disease

  2015cited by this paper
• Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.

  2015cited by this paper
• Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

  2015cited by this paper
• Parkinson's disease

  2015cited by this paper
• Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88

  2015cited by this paper
• Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.

  2015cited by this paper
• Gut microbiota are related to Parkinson's disease and clinical phenotype

  2015cited by this paper
• Transcriptional Regulators of Claudins in Epithelial Tight Junctions

  2015cited by this paper
• Vascular parkinsonism—characteristics, pathogenesis and treatment

  2015cited by this paper
• Interleukin-1β Induces Blood–Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes

  2014cited by this paper
• The gut microbiota influences blood-brain barrier permeability in mice

  2014cited by this paper
• Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

  2014cited by this paper
• Inhibiting drug efflux transporters improves efficacy of ALS therapeutics

  2014cited by this paper
• Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

  2014cited by this paper
• Enteric GFAP expression and phosphorylation in Parkinson's disease

  2014cited by this paper
• Interleukin-6 Modulation of Intestinal Epithelial Tight Junction Permeability Is Mediated by JNK Pathway Activation of Claudin-2 Gene

  2014cited by this paper
• Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.

  2014cited by this paper
• Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects.

  2014cited by this paper
• Evidence of Inflammatory System Involvement in Parkinson's Disease

  2014cited by this paper
• Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.

  2014cited by this paper
• Progression of intestinal permeability changes and alpha‐synuclein expression in a mouse model of Parkinson's disease

  2014cited by this paper
• Peptidoglycan recognition protein genes and risk of Parkinson's disease

  2014cited by this paper
• Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation.

  2014cited by this paper
• Development, maintenance and disruption of the blood-brain barrier

  2013cited by this paper
• The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes

  2013cited by this paper
• The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality

  2013cited by this paper
• Vascular Degeneration in Parkinson's Disease

  2013cited by this paper
• Colonic inflammation in Parkinson's disease.

  2013cited by this paper
• A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor

  2013cited by this paper
• Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14.

  2013cited by this paper
• of amyotrophic lateral sclerosis

  2013cited by this paper
• Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease

  2013cited by this paper
• MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease

  2013cited by this paper
• Effects of Poly (ADP-ribose) Polymerase Inhibitor 3-Aminobenzamide on Blood–Brain Barrier and Dopaminergic Neurons of Rats with Lipopolysaccharide-Induced Parkinson’s Disease

  2013cited by this paper
• Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis

  2013cited by this paper
• Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?

  2012cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012cited by this paper
• Caffeine and risk of Parkinson's disease in a large cohort of men and women

  2012cited by this paper
• Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum

  2012cited by this paper
• Changes in the astrocytic aquaporin‐4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1G93A rat model

  2012cited by this paper
• Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease

  2012cited by this paper
• Regulation of intestinal epithelial permeability by tight junctions

  2012cited by this paper
• Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

  2012cited by this paper
• Impaired blood-brain/spinal cord barrier in ALS patients.

  2012cited by this paper

• The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis

  2025cites this paper
• The Impact of the Blood–Brain Barrier and Its Dysfunction in Parkinson’s Disease: Contributions to Pathogenesis and Progression

  2024cites this paper
• Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management

  2023cites this paper
• Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice

  2022cites this paper
• Role of microbiota-derived short-chain fatty acids in nervous system disorders.

  2021cites this paper
• Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update

  2021cites this paper
• Blood–Brain Barrier Leakage Is Increased in Parkinson’s Disease

  2020cites this paper
• Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease

  2020cites this paper
• Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis

  2019cites this paper
• Phenotypic Characteristics of Human Bone Marrow-Derived Endothelial Progenitor Cells in vitro Support Cell Effectiveness for Repair of the Blood-Spinal Cord Barrier in ALS.

  2019cites this paper